Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-05-24

FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for haloperidol decanoate, resulting in changes to the labeling of this long-acting antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

SUPPL AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)